NCT00515060|Recruiting
Loading search results
Sponsor study identifier
Secondary identifiers
OTHER · Clinical Trials Reporting Program (CTRP)
observational
450
1 country
1
Study Start
January 23, 2001
Actual (reported)Primary Completion
April 30, 2028
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Study Completion
April 30, 2028
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
The Aim of this Study is to examine the feasibility of using quantitative sensory testing procedures, widely applied to the experimental study of sensory processing in humans both with and without various pain syndromes, to now characterize the psychophysical properties of neuropathic pain that has developed as a consequence of cancer therapy. Skin punch biopsies will be performed in patients with chemotherapy-induced pain to determine whether the impairment of nerve function is due to actual retraction or loss of innervation to the skin in areas affected by sensory disturbance.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
April 30, 2028
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
January 23, 2001
Actual (reported)August 9, 2007
Actual (reported)August 13, 2007
Actual (reported)April 30, 2028
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
April 30, 2028
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Participant Heat + Cold Pain Threshold
1 Hour Sensory Testing: Baseline + testing at repeated intervals throughout chemotherapy or at later follow-ups.
Participant Mechanical Testing Results <Touch Detection Threshold; Sharpness Threshold + Pain Ratings to Needle Probe; Bump Test>
1 Hour Sensory Testing: Baseline + testing at repeated intervals throughout chemotherapy or at later follow-ups.
Patients with advanced cancer entering chemotherapy or have reported pain as a result of cancer treatment.
Tests to find the threshold at which perceive stimuli.
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Patients, 18 years or older, with advanced cancer experiencing cancer therapy-induced pain.
University of Texas MD Anderson Cancer Center
Houston, Texas, 77030, United States
Patrick M. Dougherty, PhD
M.D. Anderson Cancer Center
First Submitted
August 9, 2007
First Posted
August 13, 2007
Study Start
January 23, 2001
Actual (reported)Primary Completion
April 30, 2028
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer
Contact the study team to confirm eligibility.
Study Completion
April 30, 2028
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Last Updated
June 10, 2026
Record last verified: 2026-06
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: